MediWound (MDWD) Scheduled to Post Quarterly Earnings on Wednesday

MediWound (NASDAQ:MDWD) is scheduled to post its quarterly earnings results before the market opens on Wednesday, May 29th. Analysts expect MediWound to post earnings of ($0.40) per share for the quarter.

MediWound (NASDAQ:MDWD) last issued its quarterly earnings results on Thursday, March 21st. The biopharmaceutical company reported ($0.19) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.04. The firm had revenue of $5.34 million for the quarter, compared to analyst estimates of $5.33 million. MediWound had a negative return on equity of 20.22% and a negative net margin of 35.94%. On average, analysts expect MediWound to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

MediWound Stock Performance

Shares of MDWD stock opened at $17.53 on Thursday. MediWound has a fifty-two week low of $7.10 and a fifty-two week high of $19.86. The firm has a market capitalization of $166.36 million, a P/E ratio of -22.77 and a beta of 0.81. The stock’s fifty day moving average is $16.63 and its two-hundred day moving average is $13.29.

Analysts Set New Price Targets

A number of brokerages have commented on MDWD. StockNews.com raised shares of MediWound to a “sell” rating in a research note on Wednesday, May 8th. HC Wainwright reaffirmed a “buy” rating and set a $28.00 price objective on shares of MediWound in a research report on Friday, March 22nd.

MediWound Company Profile

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.